Conference attendance at ShareSoc Leeds

Summary by AI ^BETAClose X

Tristel plc announced that its Chief Financial Officer will present an overview of the company and its strategy at the ShareSoc Growth Company investor event on April 14, 2026, in Leeds. No new financial information will be disclosed during this presentation, and a PDF of the slides will be made available on the company's investor relations website.

Disclaimer*

Tristel PLC

18 March 2026

A close-up of a logo Description automatically generated

Tristel plc

("Tristel" or the "Company")

Conference attendance at ShareSoc Leeds

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that Tristel will be presenting at the ShareSoc Growth Company investor event on 14 April 2026, which will be held at Clayton Hotel, City Walk, Sweet Street, Leeds, LS11 9AT.

Anna Wasyl, CFO of Tristel plc, will present an overview of the Company and strategy. No new information will be disclosed at the event and a PDF of the presentation will be made available on the Company's website at https://investors.tristel.com/investor-hub/.

For further information and to register for ShareSoc, please visit the event website at https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-person-event-leeds-2/.

For further information please contact:

Tristel plc			Via Walbrook PR
Matt Sassone, Chief Executive Officer			www.investors.tristel.com
Anna Wasyl, Chief Financial Officer

Walbrook PR Ltd	Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus / Lianne Applegarth / Anna Dunphy		Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

Cavendish Capital Markets Ltd			Tel: 020 7220 0500
Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance)
Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

A blue and purple sign with white text AI-generated content may be incorrect.

About Tristel plc

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO₂) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, in a format which is a sustainable alternative to commonly used pre-wetted plastic wipes.

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 250 people across 14 subsidiaries selling into 40 countries.

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

For more information about Tristel's product range please visit: https://tristel.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END